{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:43:10Z","timestamp":1791218590923,"version":"4.1.0"},"reference-count":123,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2021,1,26]],"date-time":"2021-01-26T00:00:00Z","timestamp":1611619200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nanomaterials"],"abstract":"<jats:p>Vaginal infections such as bacterial vaginosis (BV), chlamydia, gonorrhea, genital herpes, candidiasis, and trichomoniasis affect millions of women each year. They are caused by an overgrowth of microorganisms, generally sexually transmitted, which in turn can be favored by alterations in the vaginal flora. Conventional treatments of these infections consist in systemic or local antimicrobial therapies. However, in the attempt to reduce adverse effects and to contrast microbial resistance and infection recurrences, many efforts have been devoted to the development of vaginal systems for the local delivery of antimicrobials. Several topical dosage forms such as aerosols, lotions, suppositories, tablets, gels, and creams have been proposed, although they are sometimes ineffective due to their poor penetration and rapid removal from the vaginal canal. For these reasons, the development of innovative drug delivery systems, able to remain in situ and release active agents for a prolonged period, is becoming more and more important. Among all, nanosystems such as liposomes, nanoparticles (NPs), and micelles with tunable surface properties, but also thermogelling nanocomposites, could be exploited to improve local drug delivery, biodistribution, retention, and uptake in vulvovaginal tissues. The aim of this review is to provide a survey of the variety of nanoplatforms developed for the vaginal delivery of antimicrobial agents. A concise summary of the most common vaginal infections and of the conventional therapies is also provided.<\/jats:p>","DOI":"10.3390\/nano11020311","type":"journal-article","created":{"date-parts":[[2021,1,26]],"date-time":"2021-01-26T08:29:16Z","timestamp":1611649756000},"page":"311","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Recent Advances in Nanosystems and Strategies for Vaginal Delivery of Antimicrobials"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2824-4309","authenticated-orcid":false,"given":"Giulia","family":"Chindamo","sequence":"first","affiliation":[{"name":"Department of Drug Science and Technology, University of Turin, 10125 Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5335-8442","authenticated-orcid":false,"given":"Simona","family":"Sapino","sequence":"additional","affiliation":[{"name":"Department of Drug Science and Technology, University of Turin, 10125 Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8017-4956","authenticated-orcid":false,"given":"Elena","family":"Peira","sequence":"additional","affiliation":[{"name":"Department of Drug Science and Technology, University of Turin, 10125 Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4615-5812","authenticated-orcid":false,"given":"Daniela","family":"Chirio","sequence":"additional","affiliation":[{"name":"Department of Drug Science and Technology, University of Turin, 10125 Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8185-1672","authenticated-orcid":false,"given":"Marina","family":"Gallarate","sequence":"additional","affiliation":[{"name":"Department of Drug Science and Technology, University of Turin, 10125 Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,1,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0195-5616(86)50060-7","article-title":"Vaginal disorders","volume":"16","author":"Soderberg","year":"1986","journal-title":"Vet. Clin. N. Am. Small Anim. Pract."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/01.spv.0000094481.95144.3d","article-title":"Vaginal Anatomy and Physiology","volume":"9","author":"Siddique","year":"2003","journal-title":"J. Pelvic Med. Surg."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1113\/JP271694","article-title":"The vaginal microbiota, host defence and reproductive physiology","volume":"595","author":"Smith","year":"2017","journal-title":"J. Physiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.mcna.2015.01.008","article-title":"Common vaginal and vulvar disorders","volume":"99","author":"Prabhu","year":"2015","journal-title":"Med. Clin. N. Am."},{"key":"ref_5","first-page":"443","article-title":"Treatment of bacterial vaginosis: A comparison of oral metronidazole, metronidazole vaginal gel, and clindamycin vaginal cream","volume":"41","author":"Ferris","year":"1995","journal-title":"J. Fam. Pract."},{"key":"ref_6","first-page":"256","article-title":"Vaginal clindamycin and oral metronidazole for bacterial vaginosis: A randomized trial","volume":"96","author":"Paavonen","year":"2000","journal-title":"Obstet. Gynecol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.fertnstert.2004.01.025","article-title":"Why consider vaginal drug administration?","volume":"82","author":"Alexander","year":"2004","journal-title":"Fertil. Steril."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00192-012-2009-3","article-title":"The vagina as a route for drug delivery: A review","volume":"24","author":"Srikrishna","year":"2012","journal-title":"Int. Urogynecol. J. Pelvic Floor Dysfunct."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2174\/187221111795471418","article-title":"Exploring Novel Approaches to Vaginal Drug Delivery","volume":"5","author":"Gupta","year":"2011","journal-title":"Recent Pat. Drug Deliv. Formul."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S1461-5347(00)00296-0","article-title":"The scope and potential of vaginal drug delivery","volume":"3","author":"Vermani","year":"2000","journal-title":"Pharm. Sci. Technol. Today"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1080\/10717544.2017.1375575","article-title":"Expansible thermal gelling foam aerosol for vaginal drug delivery","volume":"24","author":"Mei","year":"2017","journal-title":"Drug Deliv."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1093\/infdis\/jiw159","article-title":"Current Treatment of Bacterial Vaginosis-Limitations and Need for Innovation","volume":"214","author":"Bradshaw","year":"2016","journal-title":"J. Infect. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2147\/IJWH.S23814","article-title":"Antibacterial treatment of bacterial vaginosis: Current and emerging therapies","volume":"3","author":"Menard","year":"2011","journal-title":"Int. J. Women Health"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"390","DOI":"10.15698\/mic2016.09.525","article-title":"Chlamydia trachomatis genital infections","volume":"3","author":"Ferone","year":"2016","journal-title":"Microb. Cell"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2147\/IDR.S12715","article-title":"Management of Chlamydia trachomatis genital tract infection: Screening and treatment challenges","volume":"4","author":"Taylor","year":"2011","journal-title":"Infect. Drug Resist."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1177\/1715163515570111","article-title":"Gonorrhea: Treatment update for an increasingly resistant organism","volume":"148","author":"Piszczek","year":"2015","journal-title":"Can. Pharm. J."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Unemo, M. (2015). Current and future antimicrobial treatment of gonorrhoea\u2014The rapidly evolving Neisseria gonorrhoeae continues to challenge. BMC Infect. Dis., 15.","DOI":"10.1186\/s12879-015-1029-2"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"371","DOI":"10.15698\/mic2016.09.524","article-title":"Gonorrhea\u2014An evolving disease of the new millennium","volume":"3","author":"Hill","year":"2016","journal-title":"Microb. Cell"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/S1473-3099(04)01061-8","article-title":"Syphilis and HIV: A dangerous combination","volume":"4","author":"Lynn","year":"2004","journal-title":"Lancet Infect. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1001\/jama.2014.13259","article-title":"Treatment of syphilis: A systematic review","volume":"312","author":"Clement","year":"2014","journal-title":"JAMA J. Am. Med. Assoc."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1055\/s-0042-116494","article-title":"Herpes Genitalis: Diagnosis, Treatment and Prevention","volume":"76","author":"Sauerbrei","year":"2016","journal-title":"Geburtshilfe Frauenheilkd."},{"key":"ref_22","first-page":"928","article-title":"Genital herpes: A review","volume":"93","author":"Groves","year":"2016","journal-title":"Am. Fam. Physician"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1097\/GRF.0b013e31825caa36","article-title":"HPV: Diagnosis, Prevention, and Treatment","volume":"55","author":"Hathaway","year":"2012","journal-title":"Clin. Obstet. Gynecol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0140-6736(89)90589-8","article-title":"Female to male transmission of human immunodeficiency virus type 1: Risk factors for seroconversion in men","volume":"2","author":"Cameron","year":"1989","journal-title":"Lancet"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0140-6736(06)69157-5","article-title":"HIV\/AIDS epidemiology, pathogenesis, prevention, and treatment","volume":"368","author":"Simon","year":"2006","journal-title":"Lancet"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"23","DOI":"10.32607\/20758251-2016-8-4-23-32","article-title":"Therapy of HIV Infection: Current Approaches and Prospects","volume":"8","author":"Prokofjeva","year":"2016","journal-title":"Acta Nat."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/myc.12292","article-title":"Guideline: Vulvovaginal candidosis (AWMF 015\/072), S2k (excluding chronic mucocutaneous candidosis)","volume":"58","author":"Mendling","year":"2015","journal-title":"Mycoses"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1007\/s11908-015-0484-7","article-title":"Epidemiology and Treatment of Trichomoniasis","volume":"17","author":"Kissinger","year":"2015","journal-title":"Curr. Infect. Dis. Rep."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1128\/CMR.00109-16","article-title":"Strategies for Prevention and Treatment of Trichomonas vaginalis Infections","volume":"30","author":"Bouchemal","year":"2017","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jconrel.2004.11.034","article-title":"The vagina as a route for systemic drug delivery","volume":"103","author":"Hussain","year":"2005","journal-title":"J. Control. Release"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jconrel.2017.12.004","article-title":"Polymeric gels for intravaginal drug delivery","volume":"270","author":"Cook","year":"2018","journal-title":"J. Control. Release"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S1773-2247(14)50085-8","article-title":"Mucosal nanosystems for improved topical drug delivery: Vaginal route of administration","volume":"24","author":"Basnet","year":"2014","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.addr.2014.12.004","article-title":"Polymer-based nanocarriers for vaginal drug delivery","volume":"92","author":"Nunes","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.ijpharm.2014.11.048","article-title":"Preactivated hyaluronic acid: A potential mucoadhesive polymer for vaginal delivery","volume":"478","author":"Nowak","year":"2015","journal-title":"Int. J. Pharm."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ejpb.2006.12.013","article-title":"Optimisation of polyherbal gels for vaginal drug delivery by Box-Behnken statistical design","volume":"67","author":"Chopra","year":"2007","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0168-3659(00)00314-X","article-title":"Formulation of shear rate sensitive multiple emulsions","volume":"70","author":"Muguet","year":"2001","journal-title":"J. Control. Release"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0168-3659(01)00361-3","article-title":"pH compartmented w\/o\/w multiple emulsion: A diffusion study","volume":"75","author":"Tedajo","year":"2001","journal-title":"J. Control. Release"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/10717540601067463","article-title":"W\/O\/W multiple emulsions containing nitroimidazole derivates for vaginal delivery","volume":"14","author":"Tedajo","year":"2007","journal-title":"Drug Deliv."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.ijpharm.2018.11.022","article-title":"Vaginal residence and pharmacokinetic preclinical study of topical vaginal mucoadhesive W\/S emulsions containing ciprofloxacin","volume":"554","author":"Seoane","year":"2019","journal-title":"Int. J. Pharm."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10544-019-0385-x","article-title":"Liquid crystal delivery of ciprofloxacin to treat infections of the female reproductive tract","volume":"21","author":"Pisano","year":"2019","journal-title":"Biomed. Microdevices"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.2147\/IJN.S160044","article-title":"Nanoparticle-mediated drug delivery to treat infections in the female reproductive tract: Evaluation of experimental systems and the potential for mathematical modeling","volume":"13","author":"Sims","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.carbpol.2017.04.051","article-title":"Freeze-dried cylinders carrying chitosan nanoparticles for vaginal peptide delivery","volume":"170","author":"Marciello","year":"2017","journal-title":"Carbohydr. Polym."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ejpb.2018.09.003","article-title":"Modeling of nanoparticle transport through the female reproductive tract for the treatment of infectious diseases","volume":"138","author":"Sims","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s00430-019-00622-9","article-title":"Rapid differential diagnosis of vaginal infections using gold nanoparticles coated with specific antibodies","volume":"208","author":"Hashemi","year":"2019","journal-title":"Med. Microbiol. Immunol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.carbpol.2018.03.054","article-title":"Characterization and microbiological evaluation of chitosan-alginate microspheres for cefixime vaginal administration","volume":"192","author":"Maestrelli","year":"2018","journal-title":"Carbohydr. Polym."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.carbpol.2012.08.074","article-title":"Chitosan\/alginate complexes for vaginal delivery of chlorhexidine digluconate","volume":"91","author":"Abruzzo","year":"2013","journal-title":"Carbohydr. Polym."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"118558","DOI":"10.1016\/j.ijpharm.2019.118558","article-title":"Could spray-dried microbeads with chitosan glutamate be considered as promising vaginal microbicide carriers? The effect of process variables on the in vitro functional and physicochemical characteristics","volume":"568","author":"Szymanska","year":"2019","journal-title":"Int. J. Pharm."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Aderibigbe, B.A. (2017). Metal-based nanoparticles for the treatment of infectious diseases. Molecules, 22.","DOI":"10.3390\/molecules22081370"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1099\/00222615-48-7-689","article-title":"In-vitro anti-chlamydial activities of free and Iiposomal tetracycline and doxycycline","volume":"48","author":"Sangare","year":"1999","journal-title":"J. Med. Microbiol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1038\/s41598-018-36601-y","article-title":"Autophagy nduction and PDGFR-\u03b2 knockdown by siRNA-encapsulated nanoparticles reduce chlamydia trachomatis infection","volume":"9","author":"Yang","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.nano.2014.02.009","article-title":"Poly (lactic acid)-poly (ethylene glycol) nanoparticles provide sustained delivery of a Chlamydia trachomatis recombinant MOMP peptide and potentiate systemic adaptive immune responses in mice","volume":"10","author":"Dixit","year":"2014","journal-title":"Nanomedicine"},{"key":"ref_52","unstructured":"Panyam, J., Hudson, J.A.W., and Hudson, A.P. (2014). Nanoparticles for Imaging and Treating Chlamydial Infection. (U.S. Patent 8,647,673B2)."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"7877","DOI":"10.2147\/IJN.S272736","article-title":"Antibacterial activity of chitosan nanoparticles against pathogenic N. gonorrhoea","volume":"15","author":"Alqahtani","year":"2020","journal-title":"Int. J. Nanomed."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"J\u00f8raholmen, M.W., Basnet, P., Tostrup, M.J., Moueffaq, S., and Basnet, N.S. (2019). Localized therapy of vaginal infections and inflammation: Liposomes-in-hydrogel delivery system for polyphenols. Pharmaceutics, 11.","DOI":"10.3390\/pharmaceutics11020053"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejps.2013.04.035","article-title":"Nanopharmaceuticals for improved topical vaginal therapy: Can they deliver?","volume":"50","author":"Basnet","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s11671-010-9578-1","article-title":"A novel quantum dots-based point of care test for syphilis","volume":"5","author":"Yang","year":"2010","journal-title":"Nanoscale Res. Lett."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"460","DOI":"10.3109\/21691401.2016.1170695","article-title":"Application of Goldmag immune probe in timely detection of syphilis based on GIS platform","volume":"45","author":"Tang","year":"2017","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"6688","DOI":"10.1021\/ac400517e","article-title":"Polyelectrolyte-coated gold magnetic nanoparticles for immunoassay development: Toward point of care diagnostics for syphilis screening","volume":"85","author":"Yang","year":"2013","journal-title":"Anal. Chem."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.antiviral.2012.09.020","article-title":"Prophylactic, therapeutic and neutralizing effects of zinc oxide tetrapod structures against herpes simplex virus type-2 infection","volume":"96","author":"Antoine","year":"2012","journal-title":"Antivir. Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"438","DOI":"10.15698\/mic2016.09.528","article-title":"Genital herpes: Insights into sexually transmitted infectious disease","volume":"3","author":"Jaishankar","year":"2016","journal-title":"Microb. Cell"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"3003453","DOI":"10.1126\/scitranslmed.3003453","article-title":"Mucus-Penetrating Nanoparticles for Vaginal Drug Delivery Protect Against Herpes Simplex Virus","volume":"4","author":"Ensign","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Orlowski, P., Tomaszewska, E., Gniadek, M., Baska, P., Nowakowska, J., Sokolowska, J., Nowak, Z., Donten, M., Celichowski, G., and Grobelny, J. (2014). Tannic acid modified silver nanoparticles show antiviral activity in herpes simplex virus type 2 infection. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0104113"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Or\u0142owski, P., Kowalczyk, A., Tomaszewska, E., Ranoszek-Soliwoda, K., W\u0119grzyn, A., Grzesiak, J., Celichowski, G., Grobelny, J., Eriksson, K., and Krzyzowska, M. (2018). Antiviral activity of tannic acid modified silver nanoparticles: Potential to activate immune response in herpes genitalis. Viruses, 10.","DOI":"10.3390\/v10100524"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"7022","DOI":"10.4238\/2014.March.19.2","article-title":"Inhibition effect of silver nanoparticles on herpes simplex virus 2","volume":"13","author":"Hu","year":"2014","journal-title":"Genet. Mol. Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jconrel.2012.06.008","article-title":"Polymer nanoparticles encapsulating siRNA for treatment of HSV-2 genital infection","volume":"162","author":"Steinbach","year":"2012","journal-title":"J. Control. Release"},{"key":"ref_66","first-page":"61","article-title":"Development of a novel approach to enhance the solubility of ftibamzone formulation","volume":"1","author":"Udofot","year":"2014","journal-title":"Integr. Mol. Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.colsurfb.2016.06.022","article-title":"Heterogeneous polymer composite nanoparticles loaded in situ gel for controlled release intra-vaginal therapy of genital herpes","volume":"146","author":"Ramyadevi","year":"2016","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejpb.2016.12.029","article-title":"PEGylated liposomes for topical vaginal therapy improve delivery of interferon alpha","volume":"113","author":"Basnet","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1089\/hum.2019.312","article-title":"Human papillomavirus Oncogene Manipulation Using Clustered Regularly Interspersed Short Palindromic Repeats\/Cas9 Delivered by pH-Sensitive Cationic Liposomes","volume":"31","author":"Zhen","year":"2020","journal-title":"Hum. Gene Ther."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jconrel.2016.06.028","article-title":"Freeze-dried mucoadhesive polymeric system containing pegylated lipoplexes: Towards a vaginal sustained released system for siRNA","volume":"236","author":"Furst","year":"2016","journal-title":"J. Control. Release"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1080\/10717544.2019.1568622","article-title":"A thermosensitive gel based on w1\/o\/w2 multiple microemulsions for the vaginal delivery of small nucleic acid","volume":"26","author":"Wang","year":"2019","journal-title":"Drug Deliv."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ejpb.2017.03.012","article-title":"Self-emulsifying drug delivery systems: Design of a novel vaginal delivery system for curcumin","volume":"115","author":"Nardin","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Mesquita, L., Galante, J., Nunes, R., Sarmento, B., and Neves, J. (2019). Das Pharmaceutical vehicles for vaginal and rectal administration of anti-hivmicrobicide nanosystems. Pharmaceutics, 11.","DOI":"10.3390\/pharmaceutics11030145"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Chaowanachan, T., Krogstad, E., Ball, C., and Woodrow, K.A. (2013). Drug Synergy of Tenofovir and Nanoparticle-Based Antiretrovirals for HIV Prophylaxis. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0061416"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1021\/mp4002365","article-title":"In vitro and Ex Vivo evaluation of polymeric nanoparticles for vaginal and rectal delivery of the anti-HIV drug dapivirine","volume":"10","author":"Andrade","year":"2013","journal-title":"Mol. Pharm."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"5005","DOI":"10.1021\/acs.molpharmaceut.8b00609","article-title":"Design, Characterization, and Biopharmaceutical Behavior of Nanoparticles Loaded with an HIV-1 Fusion Inhibitor Peptide","volume":"15","author":"Espina","year":"2018","journal-title":"Mol. Pharm."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.actbio.2018.10.003","article-title":"Design and development of pH-responsive polyurethane membranes for intravaginal release of nanomedicines","volume":"82","author":"Kim","year":"2018","journal-title":"Acta Biomater."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jconrel.2016.09.020","article-title":"Nanoparticles-in-film for the combined vaginal delivery of anti-HIV microbicide drugs","volume":"243","author":"Reis","year":"2016","journal-title":"J. Control. Release"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.actbio.2016.08.018","article-title":"Development and in vivo safety assessment of tenofovir-loaded nanoparticles-in-film as a novel vaginal microbicide delivery system","volume":"44","author":"Machado","year":"2016","journal-title":"Acta Biomater."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejpb.2018.02.001","article-title":"Composite films for vaginal delivery of tenofovir disoproxil fumarate and emtricitabine","volume":"138","author":"Cautela","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejps.2018.10.013","article-title":"Freeze-dried bioadhesive vaginal bigels for controlled release of Tenofovir","volume":"127","author":"Illana","year":"2019","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"3564060","DOI":"10.1155\/2017\/3564060","article-title":"Thermosensitive Chitosan Hydrogels Containing Polymeric Microspheres for Vaginal Drug Delivery","volume":"2017","author":"Yang","year":"2017","journal-title":"BioMed Res. Int."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1080\/21691401.2019.1596935","article-title":"LDH hybrid thermosensitive hydrogel for intravaginal delivery of anti-HIV drugs","volume":"47","author":"Tian","year":"2019","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1007\/s13346-019-00633-2","article-title":"Tetrahydrocurcumin-loaded vaginal nanomicrobicide for prophylaxis of HIV\/AIDS: In silico study, formulation development, and in vitro evaluation","volume":"9","author":"Mirani","year":"2019","journal-title":"Drug Deliv. Transl. Res."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ejps.2012.02.003","article-title":"Development of liposome gel based formulations for intravaginal delivery of the recombinant HIV-1 envelope protein CN54gp140","volume":"46","author":"Gupta","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Faria, M.J., Machado, R., Ribeiro, A., Gon\u00e7alves, H., Oliveira, M.E.C.D.R., Viseu, T., das Neves, J., and L\u00facio, M. (2019). Rational development of liposomal hydrogels: A strategy for topical vaginal antiretroviral drug delivery in the context of HIV prevention. Pharmaceutics, 11.","DOI":"10.3390\/pharmaceutics11090485"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1142\/S1793984410000225","article-title":"Liposomal Gels for Vaginal Delivery of the Microbicide Mc-1220: Preparation and in Vivo Vaginal Toxicity and Pharmacokinetics","volume":"1","author":"Mourtas","year":"2010","journal-title":"Nano Life"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"995","DOI":"10.3109\/03639045.2011.637048","article-title":"Development of a liposome microbicide formulation for vaginal delivery of octylglycerol for HIV prevention","volume":"38","author":"Wang","year":"2012","journal-title":"Drug Dev. Ind. Pharm."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ijpharm.2014.08.039","article-title":"Manufacturing scale-up of electrospun poly (vinyl alcohol) fibers containing tenofovir for vaginal drug delivery","volume":"475","author":"Krogstad","year":"2014","journal-title":"Int. J. Pharm."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2017.07.034","article-title":"Nanoparticle-releasing nanofiber composites for enhanced in vivo vaginal retention","volume":"144","author":"Krogstad","year":"2017","journal-title":"Biomaterials"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.biopha.2017.11.127","article-title":"Recent advances in delivery of antifungal agents for therapeutic management of candidiasis","volume":"96","author":"Sawant","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"266","DOI":"10.2478\/folmed-2018-0073","article-title":"Temperature-dependent in Situ Gel of Clotrimazole: An Experimental Study","volume":"61","author":"Patel","year":"2019","journal-title":"Folia Med."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1080\/1061186X.2018.1434660","article-title":"Development and anti-Candida evaluation of the vaginal delivery system of amphotericin B nanosuspension-loaded thermogel","volume":"26","author":"Ci","year":"2018","journal-title":"J. Drug Target."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.msec.2019.02.036","article-title":"Sodium alginate in oil-poloxamer organogels for intravaginal drug delivery: Influence on structural parameters, drug release mechanisms, cytotoxicity and in vitro antifungal activity","volume":"99","author":"Querobino","year":"2019","journal-title":"Mater. Sci. Eng. C"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jddst.2018.11.023","article-title":"Formulation and development of thermosensitive cyclodextrin-based in situ gel of voriconazole for vaginal delivery","volume":"49","author":"Deshkar","year":"2019","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"118472","DOI":"10.1016\/j.ijpharm.2019.118472","article-title":"Efficacy of ketoconazole gel-flakes in treatment of vaginal candidiasis: Formulation, in vitro and clinical evaluation","volume":"567","author":"Ellah","year":"2019","journal-title":"Int. J. Pharm."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1208\/s12249-019-1374-3","article-title":"Lecithin Microemulsion Lipogels Versus Conventional Gels for Skin Targeting of Terconazole: In Vitro, Ex Vivo, and In Vivo Investigation","volume":"20","author":"Talaat","year":"2019","journal-title":"AAPS PharmSciTech"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ijpharm.2018.11.002","article-title":"Biopharmaceutical profile of a clotrimazole nanoemulsion: Evaluation on skin and mucosae as anticandidal agent","volume":"554","author":"Ruiz","year":"2019","journal-title":"Int. J. Pharm."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.3109\/10717544.2016.1153747","article-title":"Formulation and optimization of nanoemulsion using antifungal lipid and surfactant for accentuated topical delivery of Amphotericin B","volume":"23","author":"Hussain","year":"2016","journal-title":"Drug Deliv."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1208\/s12249-016-0529-8","article-title":"Development of Clotrimazole Multiple W\/O\/W Emulsions as Vehicles for Drug Delivery: Effects of Additives on Emulsion Stability","volume":"18","author":"Calpena","year":"2017","journal-title":"AAPS PharmSciTech"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"110705","DOI":"10.1016\/j.colsurfb.2019.110705","article-title":"Dual-drugs delivery in solid lipid nanoparticles for the treatment of Candida albicans mycosis","volume":"186","author":"Carbone","year":"2020","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ejps.2017.11.029","article-title":"Controlled-release biodegradable nanoparticles: From preparation to vaginal applications","volume":"115","author":"Guerrero","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1166\/jbn.2018.2574","article-title":"In vivo vaginal fungal load reduction after treatment with itraconazole-loaded polycaprolactone-nanoparticles","volume":"14","author":"Lucena","year":"2018","journal-title":"J. Biomed. Nanotechnol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.3109\/03639045.2012.707204","article-title":"Mucoadhesive nanoliposomal formulation for vaginal delivery of an antifungal","volume":"39","author":"Karimunnisa","year":"2013","journal-title":"Drug Dev. Ind. Pharm."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ejpb.2014.02.006","article-title":"Mucoadhesive liposomes as new formulation for vaginal delivery of curcumin","volume":"87","author":"Berginc","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ejps.2018.06.030","article-title":"Lyophilized tablets for focal delivery of fluconazole and itraconazole through vaginal mucosa, rational design and in vitro evaluation","volume":"122","author":"Coutinho","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.carbpol.2018.08.084","article-title":"Electrosprayed chitosan microcapsules as delivery vehicles for vaginal phytoformulations","volume":"201","author":"Moreno","year":"2018","journal-title":"Carbohydr. Polym."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Calvo, N.L., Sreekumar, S., Svetaz, L.A., Lamas, M.C., Moerschbacher, B.M., and Leonardi, D. (2019). Design and characterization of chitosan nanoformulations for the delivery of antifungal agents. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20153686"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.ejps.2008.12.009","article-title":"Polymer-lipid based mucoadhesive microspheres prepared by spray-congealing for the vaginal delivery of econazole nitrate","volume":"36","author":"Albertini","year":"2009","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2478\/acph-2013-0027","article-title":"Bioadhesive vaginal tablets containing spray dried microspheres loaded with clotrimazole for treatment of vaginal Candidiasis","volume":"63","author":"Gupta","year":"2013","journal-title":"Acta Pharm."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ejpb.2015.07.018","article-title":"Bioadhesive vaginal drug delivery of nystatin using a derivatized polymer: Development and characterization","volume":"96","author":"Bassi","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ijpharm.2018.12.011","article-title":"Chitosan-hydroxypropyl methylcellulose tioconazole films: A promising alternative dosage form for the treatment of vaginal candidiasis","volume":"556","author":"Calvo","year":"2019","journal-title":"Int. J. Pharm."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"110635","DOI":"10.1016\/j.msec.2020.110635","article-title":"The application of nanomaterial science in the formulation a novel antibiotic: Assessment of the antifungal properties of mucoadhesive clotrimazole loaded nanofiber versus vaginal films","volume":"110","author":"Nematpour","year":"2020","journal-title":"Mater. Sci. Eng. C"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1016\/j.xphs.2018.06.017","article-title":"Amphotericin B-Loaded Poly (lactic-co-glycolic acid) Nanofibers: An Alternative Therapy Scheme for Local Treatment of Vulvovaginal Candidiasis","volume":"107","author":"Souza","year":"2018","journal-title":"J. Pharm. Sci."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jddst.2018.09.011","article-title":"Butoconazole nitrate vaginal sponge: Drug release and antifungal efficacy","volume":"48","author":"Shaker","year":"2018","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ejps.2017.12.023","article-title":"Improved vaginal retention and enhanced antifungal activity of miconazole microsponges gel: Formulation development and in vivo therapeutic efficacy in rats","volume":"114","author":"Salah","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ejpb.2015.01.019","article-title":"Mucoadhesive cellulosic derivative sponges as drug delivery system for vaginal application","volume":"95","author":"Furst","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1080\/10837450.2018.1481430","article-title":"Controlled delivery of the antiprotozoal agent (tinidazole) from intravaginal polymer matrices for treatment of the sexually transmitted infection, trichomoniasis","volume":"24","author":"Fernando","year":"2019","journal-title":"Pharm. Dev. Technol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jconrel.2016.02.024","article-title":"Propylene glycol-embodying deformable liposomes as a novel drug delivery carrier for vaginal fibrauretine delivery applications","volume":"226","author":"Li","year":"2016","journal-title":"J. Control. Release"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/1872211313666190215141507","article-title":"Nanocarriers for Vaginal Drug Delivery","volume":"13","author":"Iqbal","year":"2019","journal-title":"Recent Pat. Drug Deliv. Formul."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1002\/jps.23577","article-title":"Vaginal films for drug delivery","volume":"102","author":"Machado","year":"2013","journal-title":"J. Pharm. Sci."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.addr.2015.02.001","article-title":"Mucoadhesive and thermogelling systems for vaginal drug delivery","volume":"92","author":"Caramella","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Thakur, V., and Thakur, M. (2018). Polymer Gels in Vaginal Drug Delivery Systems. Polymer Gels. Gels Horizons: From Science to Smart Materials, Springer.","DOI":"10.1007\/978-981-10-6086-1"}],"container-title":["Nanomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-4991\/11\/2\/311\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:15:36Z","timestamp":1760159736000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-4991\/11\/2\/311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,26]]},"references-count":123,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,2]]}},"alternative-id":["nano11020311"],"URL":"https:\/\/doi.org\/10.3390\/nano11020311","relation":{},"ISSN":["2079-4991"],"issn-type":[{"value":"2079-4991","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,26]]}}}